Clinical Trial Update: Impact of Remission Induction Chemotherapy Prior to Allogeneic SCT in Relapsed and Poor-response Patients With AML [Phase 3]

View source ↗

Summary

Phase 3 trial assessing whether remission induction chemotherapy before allogeneic stem cell transplant improves outcomes in relapsed or poor-response acute mye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: DKMS gemeinnützige GmbH | Conditions: Acute Myeloid Leukemia | Phase 3 | Status: COMPLETED